DGX insider sale notice: 526 vested shares listed

DGX Form 144 notice reports an intended sale of common stock by a reporting person and prior open‑market sales.

Rhea-AI Filing Summary

DGX Form 144 notice reports an intended sale of common stock by a reporting person and prior open‑market sales. The notice lists 526 shares tied to restricted stock vesting on 02/23/2026 and prior sales of 1,111 common shares on 02/19/2026 that generated $227,566.13. The broker listed is Fidelity Brokerage Services LLC and the filing shows 03/03/2026 on the NYSE.

Insights

Insider Transactions Specialist

Notice records a planned sale of vested restricted shares and recent open‑market disposals.

The excerpt lists 526 common shares associated with restricted stock vesting on 02/23/2026, and prior sales of 1,111 shares on 02/19/2026 for $227,566.13. The broker is Fidelity Brokerage Services LLC.

These entries are routine reporting of insider transactions; cash flow details for the planned sale beyond the listed share count are not provided in the excerpt. Subsequent regulatory filings or confirmations would show execution details and any changes.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the DGX Form 144 disclose about upcoming sales?

The filing discloses a planned sale of 526 common shares tied to restricted stock vesting on 02/23/2026. The entry lists the broker as Fidelity Brokerage Services LLC and is filed on 03/03/2026.

Did the reporting person recently sell DGX stock?

Yes, the filing reports prior sales of 1,111 common shares on 02/19/2026. Those sales generated $227,566.13 according to the excerpt.

Who is the broker handling the DGX transactions?

The excerpt lists Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI as the broker for the transactions. The venue noted is the NYSE.

What date appears on the DGX Form 144 filing?

The filing shows the date 03/03/2026. The securities to be sold are tied to a vesting event dated 02/23/2026 and prior sales dated 02/19/2026.

How much cash was reported from recent DGX share sales?

The excerpt shows proceeds of $227,566.13 from sales of 1,111 common shares on 02/19/2026. No further proceeds detail is provided for the planned sale of 526 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 12:12 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001222679
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	QUEST DIAGNOSTICS INC
SEC File Number	001-12215
Address of Issuer	500 PLAZA DRIVE SECAUCUS NEW JERSEY 07094
Phone	9735202700
Name of Person for Whose Account the Securities are To Be Sold	PREVOZNIK MICHAEL E
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	526	109265.98	109866320	03/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2026	Restricted Stock Vesting	Issuer			526	02/23/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Prevoznik 500 Plaza Drive Secaucus NJ 07094	Common	02/19/2026	1111	227566.13

144: Remarks and Signature

Remarks
Date of Notice	03/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/30/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Audrey McMillen, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael Prevoznik
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)